August 5, 2026 · Annals of surgical oncology · DOI: 10.1245/s10434-026-20340-w

Clinical and Functional Impact of CHMP3 in Pancreatic Ductal Adenocarcinoma

Listen to this summary

The authors aimed to evaluate the clinical and biological significance of CHMP3 in pancreatic ductal adenocarcinoma (PDAC) and its potential as a prognostic marker. They found that elevated CHMP3 expression correlates with poorer overall and disease-free survival, and its knockdown in cell lines reduced proliferation and increased sensitivity to gemcitabine. Despite these findings, the authors caution that the prognostic implications of CHMP3 may be confounded by treatment factors, necessitating further validation.

Yosuke Igarashi, Yoshihiro Shirai, Shiko Honma, Yuto Yamahata, Munetoshi Akaoka, Yoshiaki Tanji, Tomohiko Taniai, Mitsuru Yanagaki, Koichiro Haruki, Kenei Furukawa, Masayuki Shimoda, Toru Ikegami

This is one of 33,000+ journals available on OSLR. Try it free for 14 days.

Free 14-day trial. 33,000+ journals. Cancel anytime.

14-day free trial. No commitment.

"Oslr has become part of my weekly routine on my day off. The clinical relevance of the summaries is outstanding — I'd rate it 9/10. Being able to consume research hands-free is a huge advantage for busy physicians."

Dr. Jennifer Thompson

Dr. Jennifer Thompson

Portland, OR

Stay current without falling behind

33,000+ journals. 3-minute audio summaries. Free for 14 days.

Download on the App StoreGet it on Google Play